.png){kind=icon}
返回
Intercompetitor Licensing and Product Innovation
.png){kind=icon}
PRE
AI
DOI：10.1177/0022243718802846.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
This article explores how intercompetitor licensing between an incumbent and an entrant affects market competition and the entrant's optimal product quality. In the model, the incumbent has a noncore technology that is used for the noncore attribute of the final product, and the entrant has a new core technology to introduce a new, higher-quality product. For the noncore technology of its product, the entrant can either license it from the incumbent or develop it in-house. The authors show that a royalty licensing contract of the noncore technology between the incumbent and the entrant has a competition-alleviating effect. More important, the effect of such licensing on the entrant's optimal quality depends on whether its core technology can significantly or only incrementally increase its product quality over the incumbent's product quality. The royalty contract will tend to increase the entrant's optimal quality when the entrant's core technology can offer a significant quality improvement over the incumbent's. By contrast, if the entrant's technology can raise its product quality only incrementally over the incumbent's product quality, the royalty contract will tend to reduce the entrant's optimal quality. A wide range of royalty licensing contracts are mutually acceptable; the incumbent (entrant) can benefit from such a contract even when the entrant pays a total royalty fee that is lower (higher) than its alternative research-and-development cost. These results hold even when the incumbent endogenously chooses its royalty licensing fee. The main results are robust to several alternative modeling assumptions (e.g., alternative game sequence, endogenous quality decision by the incumbent, alternative licensing contract).
Keyword:
competition
intercompetitor licensing
pricing
product quality
royalty
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
J
IF:
5
论文数:
2.6K
被引数:
2.9W
机构
引用论文
Clinical characteristics of physician-diagnosed patients with multiple chemical sensitivity in Japan
PREAI
分享收藏Spatiotemporal variations and bioaccumulation of per- and polyfluoroalkyl substances and oxidative conversion of precursors in shallow lake water.png)
Chemosphere
ChemosphereIF0
PREAI
分享收藏
分享收藏
查看更多内容